Research News and Research

RSS

Interleukin Genetics second-quarter net loss from continuing operations decreases to $1.9 million

Interleukin Genetics, Inc. today announced financial and operational results for the second quarter ended June 30, 2010.

13 Aug 2010

U-M dentistry agrees to use Interleukin's PST test for gum disease clinical study

University of Michigan School of Dentistry has signed an agreement with Interleukin Genetics Inc. to conduct what may be the largest clinical study to date using genetic testing to assess the risk for gum disease.

13 Aug 2010

BioSante second-quarter net loss increases to $10.8 million

BioSante Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2010.

13 Aug 2010

CPF urges people to consider clinical trials for pulmonary fibrosis

The Coalition for Pulmonary Fibrosis (CPF) is urging the more than 128,000 people known to suffer from the deadly lung disease, pulmonary fibrosis (PF), to consider clinical trials, including two new ones funded by the National Institutes of Health (NIH). Clinical trials of potential drug therapies are critical to the discovery of treatments for any disease and for a disease like PF that claims as many lives each year as breast cancer with virtually no survivors, they are the likely path to answers and saved lives.

13 Aug 2010

Severe inflammatory response to initial UTI causes bladder damage: Research

The immune system may open the door to recurrent urinary tract infections (UTIs) by overdoing its response to an initial infection, researchers at Washington University School of Medicine in St. Louis have found.Researchers showed in mice that severe inflammatory responses to an initial UTI cause bladder damage and allow infection to persist longer. After one to two weeks of infection, the bladder wall undergoes additional changes that leave mice more vulnerable to later infection. Suppressing the immune system during initial infection decreases these vulnerabilities, they report Aug. 12 in PLoS Pathogens.

13 Aug 2010

Mass. docs will soon track patients who abuse prescription drugs; Wis. Catholic Church employees now eligible for birth control

The Boston Globe: "With a few computer keystrokes, Massachusetts physicians will soon be able to identify patients who travel from clinic to clinic in pursuit of potent prescription drugs that feed lethal addictions. State health regulators yesterday unanimously approved the new detection system designed to stop 'doctor shopping' by addicted patients who try to dupe doctors into prescribing narcotics. The practice, specialists said, has fueled a surge in drug-related deaths in Massachusetts" (Smith, 8/12).

13 Aug 2010

Exposure to immune proteins during pregnancy increases risk for schizophrenia in offspring

Infections like the flu are common occurrences during pregnancy, and research has shown that children born to mothers who suffered from flu, viruses and other infections during pregnancy have about a 1.5 to 7 times increased risk for schizophrenia. A new study out of Temple University examines what's behind that link.

13 Aug 2010

Trimeris second-quarter royalty revenue decreases to $1.6 million

Trimeris, Inc., or the "Company," today announced financial results for the quarter ended June 30, 2010, reporting net income of $1.3 million, or $0.06 per share, which was unchanged from the quarter ended June 30, 2009. Comparisons of net income between the quarters ended June 30, 2010 and June 30, 2009 are affected by a one-time adjustment in the second quarter of 2009 that increased operating expenses for that period by $496,000.

13 Aug 2010

HIV infected injection drug users likely to have kidney disease: Study

Poor kidney function is common among injection drug users, particularly those with HIV, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that clinicians should monitor the kidney function of HIV-infected injection drug users and consider them candidates for medical treatments to protect their kidneys when appropriate.

13 Aug 2010

The Australian examines development of low-cost water purifiers by Indian companies

The Australian reports on how four large businesses in India are developing low-cost water purifiers for some of the country's "poorest of the poor."

13 Aug 2010

Study examines impact of microvascular decompression surgery for type 2 diabetes

A team of Allegheny General Hospital (AGH) physicians led by neurosurgical pioneer Peter Jannetta, MD, has made an important new discovery linking the central nervous system to the onset and progression of type 2 diabetes mellitus.Reporting today in the journal Surgical Neurology International, Dr. Jannetta and his colleagues present evidence from a prospective clinical trial that vascular compression of a section of the brain called the medulla oblongata is a factor in some patients with type 2 diabetes and that microvascular decompression surgery (MVD) may be an effective treatment for the condition.

13 Aug 2010

Prices drop for PBMs; Pharmacy lobby opposes survey regarding Medicaid prices

Prices are falling for major pharmacy benefit managers, such as Medco and CVS Caremark, as the firms compete for clients, but the falling rates "don't appear to be sliding into a frenzy of unreasonable pricing," The Wall Street Journal reports. "In the current 'selling season,' when PBMs look to sign customers for the following year, discounts on new contracts have deepened by one or two percentage points, on average, from a year ago.

13 Aug 2010

Study finds Olaparib can reduce tumor size in ovarian cancer women

Understanding the underlying genetic weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations.

13 Aug 2010

Chronic pain affects higher proportion of women than men: Research

Women experience chronic pain longer, more intensely and more often than men, according to a psychologist who works with both men and women dealing with diseases and conditions that leave them suffering.

13 Aug 2010

Cancer Research Technology grants Valirx global rights to develop VAL 201 for cancer treatment

Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.

13 Aug 2010

GOP Rep. Ryan potential 'foil' for Obama; Candidates consider reform's role in races

The New York Times: Rep. Paul Ryan, "as you may have heard, is the Republican star of the moment. A 40-year-old from southeastern Wisconsin serving his sixth term in the House, Mr. Ryan has been getting a lot of attention for his 'Roadmap for America's Future,' an unusually austere proposal to vanquish the federal debt by, among other things, partly dismantling Social Security and Medicare as they currently exist."

13 Aug 2010

Tracking heart rate can provide important marker of health issues: Research

An elevated resting heart rate that develops or persists during follow-up is associated with a significantly increased risk of death, whether from heart disease or other causes, researchers from the Ronald O. Perelman Heart Institute at NewYork-Presbyterian Hospital/Weill Cornell Medical Center found studying outcomes in more than 9,000 patients.

13 Aug 2010

OXiGENE reports $2.5M net income for second-quarter 2010 vs. $5.3M net loss for same period in 2009

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter and six months ended June 30, 2010, and presented an update on recent clinical and corporate progress.

13 Aug 2010

WHO releases H1N1 Emergency Committee roster

Five of the 15 experts advising the WHO on H1N1 (swine flu) had ties to the pharmaceutical industry, "including for flu vaccine research," according to the Emergency Committee members' list released by the agency Wednesday, Agence France-Presse reports.

13 Aug 2010

Transdel second-quarter 2010 net loss decreases to $0.5 million

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced financial results for the three and six months ended June 30, 2010 and other activity during the second quarter.

13 Aug 2010

Research News and Research

Interleukin Genetics second-quarter net loss from continuing operations decreases to $1.9 million

U-M dentistry agrees to use Interleukin's PST test for gum disease clinical study

BioSante second-quarter net loss increases to $10.8 million

CPF urges people to consider clinical trials for pulmonary fibrosis

Severe inflammatory response to initial UTI causes bladder damage: Research

Mass. docs will soon track patients who abuse prescription drugs; Wis. Catholic Church employees now eligible for birth control

Exposure to immune proteins during pregnancy increases risk for schizophrenia in offspring

Trimeris second-quarter royalty revenue decreases to $1.6 million

HIV infected injection drug users likely to have kidney disease: Study

The Australian examines development of low-cost water purifiers by Indian companies

Study examines impact of microvascular decompression surgery for type 2 diabetes

Prices drop for PBMs; Pharmacy lobby opposes survey regarding Medicaid prices

Study finds Olaparib can reduce tumor size in ovarian cancer women

Chronic pain affects higher proportion of women than men: Research

Cancer Research Technology grants Valirx global rights to develop VAL 201 for cancer treatment

GOP Rep. Ryan potential 'foil' for Obama; Candidates consider reform's role in races

Tracking heart rate can provide important marker of health issues: Research

OXiGENE reports $2.5M net income for second-quarter 2010 vs. $5.3M net loss for same period in 2009

WHO releases H1N1 Emergency Committee roster

Transdel second-quarter 2010 net loss decreases to $0.5 million

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence